Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The clinical trials market was valued at USD 58.04 Billion in 2025. It is poised to grow at a CAGR of 7.78% during the forecast period of 2026-2035, and reach USD 122.77 Billion by 2035. The market is driven by increasing R&D investments, growing prevalence of chronic diseases, and rising adoption of decentralized trials, accelerating drug development timelines and improving patient recruitment globally.
Key Market Trends and Insights
- By phase, the phase III segment held the largest market share of more than 53% in the historical period.
- By therapeutic area, oncology dominated with a market share exceeding 29% in the historical period.
- Based on region, North America market held the largest share over 50% of the global market in the historical period.
Market Size and Forecast
- Market Size (2025): USD 58.04 Billion
- Projected Market Size (2035): USD 122.77 Billion
- CAGR (2026-2035): 7.78%
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In March 2026, CenExel expanded its U.S. clinical research network by developing a new Phase I inpatient facility with advanced infrastructure for neurology trials. This expansion supports growing demand for specialized trial environments, particularly for complex and early-phase studies requiring controlled clinical settings.
-
In October 2025, Thermo Fisher Scientific announced the acquisition of Clario for up to USD 9.4 billion to strengthen clinical trial data and endpoint services. The deal enhances trial efficiency, data analytics, and global development capabilities, reflecting rising demand for integrated solutions across clinical research workflows.
-
In August 2025, THL Partners acquired a majority stake in Headlands Research, a clinical trial site network, for approximately USD 600 million. This investment highlights growing financial interest in site-based research infrastructure, driven by increasing trial volumes, patient demand, and the need for scalable clinical operations globally.
Compound Annual Growth Rate
7.78%
Value in USD Billion
2026-2035
*this image is indicative*
Clinical Trials Market Overview
The market is expanding steadily, driven by increasing drug development activities, rising prevalence of chronic diseases, and growing demand for innovative therapies. Advancements in digital technologies, including decentralized trial models and data analytics, are improving efficiency and patient recruitment. Additionally, strong regulatory support and increased outsourcing to CROs are enhancing trial execution globally, supporting sustained market growth. The market reached a value of approximately USD 58.04 Billion in 2025.
Clinical Trials Market Growth Drivers
Strategic Acquisitions Driving the Market Expansion
The growing demand for integrated data solutions and the increasing complexity of global trials are major market drivers. For instance, in October 2025, Thermo Fisher Scientific acquired Clario for up to USD 9.4 billion to strengthen data and analytics capabilities. This move is projected to enhance operational efficiency through improved endpoint management, accelerating trial timelines and supporting more precise and scalable clinical development worldwide.
Clinical Trials Market Trends
Key trends shaping the market include rising decentralization, advanced analytics adoption, and increasing investment in clinical research infrastructure.
Expansion of Advanced Trial Facilities to Propel the Market Value
Rising demand for early-phase research infrastructure and increasing complexity of neurological studies are key factors supporting market expansion. For instance, in March 2026, CenExel expanded its U.S. network by launching a phase I inpatient facility tailored for neurology trials. This development is expected to enhance capacity for phase I II III IV trials, improving efficiency, patient monitoring, and supporting advanced clinical research growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical Trials Market Segmentation
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Others
Market Breakup by Service Type
- Laboratory Services
- Bioanalytical Testing Services
- Cell-Based Assay
- Virology Testing
- Serology, Immunogenicity, and Neutralizing Antibodies
- PK/PD Testing
- Method Development, Optimization and Validation
- Biomarker Testing
- Other Bioanalytical Testing Services
- Decentralized Clinical Trial Services
- Patient Recruitment
- Site Identification
- Analytical Testing Services
- Clinical Trial Supply and Logistic Services
- Protocol Designing
- Clinical Trial Data Management Services
- Medical Device Testing Services
- Other Services
Market Breakup by Therapeutic Areas
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women's Health
- Other Therapeutic Areas
Market Breakup by Application
- Small Molecules
- Monoclonal Antibodies
- Vaccine
- Cell & Gene Therapy
- Other Applications
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clinical Trials Market Share
Oncology Likely to Dominate the Market Segment by Therapeutic Area
Oncology remains the leading therapeutic area, accounting for over 29% of the global market share during the historical period. The segment’s dominance is supported by increasing cancer prevalence and continuous innovation in targeted therapies. Advancements in trial methodologies, including adaptive design, are improving study efficiency, optimizing outcomes, and accelerating the development of novel oncology treatments worldwide.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Clinical Trials Market Analysis by Region
North America leads the global market, holding over 50% share in the historical period. The region benefits from strong regulatory frameworks, advanced healthcare infrastructure, and significant R&D investments. High industry presence and extensive CRO outsourcing further enhance operational efficiency, enabling faster study execution, robust data management, and sustained regional market leadership.
Leading Players in the Clinical Trials Market
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
IQVIA
IQVIA, headquartered in Durham, North Carolina, United States, was established in 2016 through the merger of IMS Health and Quintiles. The company offers comprehensive clinical trial services, including data analytics, real-world evidence, and technology-driven solutions. Its portfolio supports end-to-end drug development with strong emphasis on decentralized trial models improving efficiency and patient engagement globally.
PAREXEL International Corporation
PAREXEL International Corporation, headquartered in Durham, North Carolina, United States, was founded in 1982. The company provides biopharmaceutical services, including clinical development, regulatory consulting, and market access solutions. Its clinical trial portfolio focuses on optimizing patient recruitment strategies, ensuring efficient enrollment, improved retention, and enhanced trial timelines across global therapeutic areas.
ICON plc
ICON plc, headquartered in Dublin, Ireland, was established in 1990. The company delivers outsourced clinical development and commercialization services to pharmaceutical and biotechnology firms. Its portfolio spans full-service clinical trials, leveraging advanced protocol design capabilities to enhance study outcomes, streamline processes, and support complex global trials across diverse therapeutic indications.
Syneos Health Inc.
Syneos Health Inc., headquartered in Morrisville, North Carolina, United States, was founded in 2017. The company offers integrated biopharmaceutical solutions, combining clinical and commercial services. Its clinical trials portfolio emphasizes regulatory compliance and operational excellence, with strong adherence to GCP compliance, ensuring quality, safety, and reliability throughout the clinical development lifecycle.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are WuXi AppTec, Laboratory Corporation of America Holdings, Charles River Laboratories, Thermo Fisher Scientific Inc., Fortrea Inc., and Advanced Clinical.
Key Questions Answered in the Clinical Trials Market Report
- What was the clinical trials market value in 2025?
- What is the clinical trials market forecast outlook for 2026-2035?
- What major factors aid the demand for clinical trials market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major clinical trials market trends?
- Which service type is expected to dominate the market segment?
- Which phase is expected to dominate the market segment?
- Which therapeutic areas is expected to dominate the market segment?
- Who are the key players in the clinical trials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share